CDK4 and cancer: CDK4/6 is a key regulator of the transition from G1 to S phase (Yuan et al., 2021) and the inhibition of CDK4/6 blocks progression of the cell cycle from the G1 to S phase in cancer cells (Anders et al., 2011; O’Leary et al., 2016; Kato et al., 2021).